Oncolytic Viral Therapy Market Trends, Analysis Research And Projections For 2022-2026

1
Oncolytic Viral Therapy Market Increasing Cases
of Cancers and Malignant Tumours to Maintain
Steady Growth for Oncolytic Viral Therapy
Market Cancer has emerged as one of the leading
causes of death across the world. With spiralling
cases of malignant tumours globally, an
increasing requirement for effective cancer
therapeutics has emerged. Present treatment
options have proved effective but surgical
inventions, radiotherapies, chemotherapies, and
immunotherapies have their own restrictions.
Hence, in order to ensure stable lifestyles for
cancer-affected patients, there has been an
increased focus on developing new methods of
treatment. Oncolytic viral therapy has been
gaining popularity due to its non-pathogenic,
targeted, and transformative treatment line.
This has ensued multiple oncolytic viruses such
herpesvirus, adenovirus, and vaccinia virus to
be put under clinical trials. The increasing use
of these viruses for treating cancer and aid
diagnosis has been a primary contributor to the
market growth for oncolytic virus
therapy. Looking For a Sample of This Report?
Request the Same Here https//www.fairfieldmarke
tresearch.com/report/oncolytic-viral-therapy-
market/request-sample Hospital and Solid Tumour
Segments Take Up Popular Shares of Market Growth
for Oncolytic Viral Therapy Market Oncolytic
viruses can activate local immune responses,
induce T-cell priming and infiltration, and
counteract cancer-mediated evasion of the immune
system. This has made it possible for these
viruses to be used in combinations with various
cancer immunotherapies. Due to this reason,
tolerability, specificity, and potency of these
therapies has increased ten-fold. This is
expected to serve as a key driver for generating
significant market revenues over the projected
period. Increasing cases of malignant cancer has
ensued an escalated use of oncolytic virus.
Similarly, lack of existing treatment options
for metastatic tumours is instigating aggressive
research in the area using oncolytic viruses. In
collective gratitude to these factors and
developing advancements in oncolytic viral
therapies for solid tumours, the market for
oncolytic viral therapy is undergoing tremendous
growth. Furthermore, increasing number of
patients being admitted to hospitals for cancer
treatment is also projected to stimulate market
growth. This is due to availability of growing
network of hospitals dedicated to cancer
treatment, skilled professionals and advanced
medical facilities, and increasing investment to
accelerate development of robust healthcare
infrastructure. North America Transcends as an
Established Region Whereas Countries of APAC
Region Expected to Witness Substantial Growth
2

• North America holds a significant share of the
  market for oncolytic viral therapy. This is due
  to the presence of a well-established healthcare
  infrastructure and considerable investments in
  research and development in the region. Europe as
  well constitutes satisfactory growth in the
  area. Asia Pacific is expected to register rapid
  growth in revenue over the forecast period owing
  to rising investment to accelerate research and
  development activities in oncology, rapid
  adoption of advanced cancer treatment approaches,
  increasing prevalence of cancer, growing number
  of clinical trials and preclinical studies for
  oncolytic viruses, and development of advanced
  healthcare facilities.
• Check Complete Report Details of market _at_
  https//www.fairfieldmarketresearch.com/report/onc
  olytic-viral-therapy-market
• Major Companies Dominating the Market for
  Oncolytic Viral Therapy
• Some of the major companies with a foothold in
  the global oncolytic viral therapy market
  include Oncolytics Biotech, Inc., Amgen Inc.,
  Sorrento Therapeutics, Inc., Transgene SA,
  Daiichi Sankyo Company, Limited., Shanghai Sunway
  Biotech Co., Ltd., Takara Bio Inc., PsiOxus
  Therapeutics, SillaJen, Inc. and ViroCure. These
  companies are expected to leverage the
  tremendous potential of research centres to
  develop indigenous capabilities.
• Latest Trending Reports
• Drug Discovery Informatics Market Global Industry
  Analysis (2017 - 2021) - Growth Trends and
  Market Forecast (2022 - 2028)
• Healthcare IT Integration Market Global Industry
  Analysis (2017 - 2021) - Growth Trends and
  Market Forecast (2022 - 2028)
• Medical Adhesives Market Global Industry Analysis
  (2017 - 2021) - Growth Trends and Market
  Forecast (2022 - 2028)
• Infertility Treatment Market Global Industry
  Analysis (2017 - 2021) - Growth Trends and
  Market Forecast (2022 - 2028)
• Healthcare BPO Market Global Industry Analysis
  (2017 - 2021) - Growth Trends and Market
  Forecast (2022 - 2028)
• About Us
• Fairfield Market Research is a UK-based market
  research provider. Fairfield offers a wide
  spectrum of services, ranging from customized
  reports to consulting solutions. With a strong
  European footprint, Fairfield operates globally
  and helps businesses navigate through business
  cycles, with quick responses and multi-pronged
  approaches. The company values an eye for
  insightful take on global matters, ably backed by
  a team of exceptionally experienced researchers.
  With a strong repository of syndicated market
  research reports that are continuously published
  updated to ensure the ever-changing needs of
  customers are met with absolute promptness.
• Contact
• Fairfield Market Research
• London, UK

3
UK 44 (0)20 30025888 USA (Toll-free) 1 (844)
3829746 Web https//www.fairfieldmarketresearch.c
om/ Email sales_at_fairfieldmarketresearch.com Follo
w Us LinkedIn